Related Experiment Video
Updated: Oct 23, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
Jean-Jacques Mourad1, Jaehyo Suhl
1Department of Internal Medicine and European Society of Hypertension Excellence Centre, Groupe hospitalier Paris Saint-Joseph, Paris, France, jjmourad@ghpsj.fr.
No abstract available in PubMed .
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome IV: Interprofessional Care
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

